Walleye Trading’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Walleye Trading’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,356	Closed	-$10K	–	5747
2022 Q3	$10K	Buy	13,356 +2,772	+26%	+$1.76K	﹤0.01%	4554
2022 Q2	$1K	Hold	10,584	–	–	﹤0.01%	5031
2022 Q1	$2K	Hold	10,584	–	–	﹤0.01%	5219
2021 Q4	$6K	Buy	+10,584	New	+$7.39K	﹤0.01%	5197

Walleye Trading's FLACW Position: Q4 2022 in Review

Walleye Trading sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 13,356 shares — an estimated $10K sold.

Walleye Trading first reported a position in FLACW in Q4 2021 and held it in 4 quarters. The position peaked at $10K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

Walleye Trading reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
Walleye Trading sold 13,356 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $10K.
Walleye Trading first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q4 2021 and held it in 4 quarters.
Walleye Trading's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $10K in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on Walleye Trading's 13F filing for Q4 2022, filed 14 Feb 2023.